Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Chronogen
company
About
Chronogen Inc. a biotechnology company headquartered in Montreal, Canada.
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $17M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 1998
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$17M
Chronogen has raised a total of
$17M
in funding over 2 rounds. Their latest funding was raised on
Nov 26, 2003 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 26, 2003 | Series B | $17M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Chronogen is funded by 2 investors.
CDP Capital Technology Ventures
and T2C2 Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
CDP Capital Technology Ventures
|
— | Series B |
T2C2 Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
